Estriol is one of the three main types of estrogen naturally produced by the human body, along with estradiol and estrone. Among these, estriol is unique because it plays its most significant role during pregnancy. Outside of pregnancy, estriol levels are very low and barely detectable. However, during pregnancy, estriol production dramatically increases as the placenta, fetus, and mother work together to create this hormone.
Biologically, estriol acts by binding to estrogen receptors—proteins on cells that respond to estrogen signals. Compared to estradiol, the strongest estrogen, estriol is considered much weaker, with only about 10 to 20 percent of the binding strength. Interestingly, estriol can act as a partial agonist, meaning it can both activate and block estrogen receptors depending on the circumstances. In the presence of strong estrogens like estradiol, estriol may help soften estrogenic effects, offering a protective balance.
Estriol levels in pregnant women are closely tied to fetal health. The fetus’s adrenal glands produce hormone precursors, which are processed by the fetal liver and then converted into estriol by the placenta. Therefore, measuring estriol can offer insights into how well the fetus and placenta are functioning. A sudden rise in estriol often occurs just before labor begins, suggesting estriol may play a role in starting the birth process.
From a clinical perspective, estriol has promising applications beyond pregnancy. For women with multiple sclerosis (MS), estriol combined with standard treatment has been shown to lower relapse rates, offering hope for managing this challenging condition. Estriol also helps postmenopausal women by improving vaginal health and reducing the frequency of urinary tract infections (UTIs). Because it primarily acts locally when given intravaginally and does not significantly increase estrogen levels throughout the body, it is considered a safer option even for women with a history of hormone-sensitive breast cancer.
There is an interesting duality when it comes to estriol and breast cancer. Although estriol can stimulate breast cancer cells in lab settings, some evidence suggests it may actually protect against breast cancer when present naturally during pregnancy. This protective effect may come from estriol’s ability to block stronger estrogens from overly stimulating breast tissue.
Finally, estriol is increasingly recognized for its environmental footprint. As a natural hormone excreted by humans and animals, it can enter water and soil systems, raising concerns about potential health effects on both wildlife and people, particularly regarding hormone-related cancers and ecological imbalances.